Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Atlanta GA, Nashville TN, Germantown TN,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
for
Hereditary Leiomyomatosis and Renal Cell Carcinoma,
Location: Atlanta GA, Columbus OH, Bethesda MD, Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT04981509
Phase2, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Location: Atlanta GA, Charlotte NC, Nashville TN, Durham NC,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06765109
Phase3, Recruiting
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
for
Malignant Brain Glioma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 0 - 21
Code: NCT04908709
Recruiting
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
for
Plasma Cell Myeloma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT05208307
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: Atlanta GA, Birmingham AL, Louisville KY, St Louis MO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase2, Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
for
Low Grade Glioma, Malignant Brain Glioma,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06132685
Phase2, Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Atlanta GA, Cincinnati OH, Tampa FL, Cleveland OH,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase3, Recruiting
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
for
Metastatic Urothelial Carcinoma,
Location: Atlanta GA, Miami FL, New York NY, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06439836
Phase1, Recruiting
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
for
Salivary Gland Cancer, HER2 Gene Mutation
Location: Atlanta GA, Chicago IL, Basking Ridge NJ, Middletown NJ,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04620187
Phase2, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Atlanta GA, Augusta GA, Charlotte NC, Monroe NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase3, Recruiting
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
for
Stage III Prostate Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University
Sex: Male
Age: 18+
Code: NCT04725903
Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Atlanta GA, Pinehurst NC, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase2, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for
NSCLC Stage IV
Location: Atlanta GA, Hickory NC, Charleston SC, Nashville TN,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase3, Recruiting
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
for
Severe Aplastic Anemia
Location: Atlanta GA, Charlotte NC, Birmingham AL, Nashville TN,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 3 - 70+
Code: NCT06517641
Phase2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Atlanta GA, Greenville SC, Macon GA, Augusta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase3, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Atlanta GA, Jacksonville FL, Wilson NC, Orlando FL,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
for
Nasopharyngeal Cancer Recurrent
Location: Atlanta GA, Cincinnati OH, Little Rock AR, Cleveland OH,
Sponsor: Coherus Oncology, Inc.
Sex: All
Age: 12+
Code: NCT06457503
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Atlanta GA, Greenville SC, Charlotte NC, Birmingham AL,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer